Cargando…
Clinical analysis of bevacizumab targeting therapy in treating early colorectal carcinoma after operation
Clinical effects of bevacizumab target therapy in treating early colorectal carcinoma (CRC) after resection were analyzed. Ninety-two patients diagnosed with early CRC and treated with endoscopic mucosal resection for the first time were selected for the study. They were randomly divided into the co...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452938/ https://www.ncbi.nlm.nih.gov/pubmed/28599469 http://dx.doi.org/10.3892/ol.2017.6087 |